Helder Veras Ribeiro-Filho (Helder V Ribeiro-Filho)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Coronavirus Disease

Regulatory T Cells

Top Venues

bioRxiv : the preprint server for biology

Science signaling

PLoS computational biology

This page only lists publications with an associated author ORCID identifier.

Publications

Helder Veras Ribeiro-Filho, Gabriel Ernesto Jara, João Victor da Silva Guerra, Melyssa Cheung, Nathaniel R Felbinger, José Geraldo de Carvalho Pereira, Brian G Pierce, Paulo Sergio Lopes de Oliveira
Exploring the Potential of Structure-Based Deep Learning Approaches for T cell Receptor Design. bioRxiv : the preprint server for biology (2024)
Helder Veras Ribeiro-Filho, Gabriel Ernesto Jara, João Victor da Silva Guerra, Melyssa Cheung, Nathaniel R Felbinger, José Geraldo de Carvalho Pereira, Brian G Pierce, Paulo Sergio Lopes de Oliveira
Exploring the Potential of Structure-Based Deep Learning Approaches for T cell Receptor Design. bioRxiv : the preprint server for biology (2024)
Helder Veras Ribeiro-Filho, Gabriel Ernesto Jara, Fernanda Aparecida Heleno Batista, Gabriel Ravanhani Schleder, Celisa Caldana Costa Tonoli, Adriana Santos Soprano, Samuel Leite Guimarães, Antonio Carlos Borges, Alexandre Cassago, Marcio Chaim Bajgelman, Rafael Elias Marques, Daniela Barretto Barbosa Trivella, Kleber Gomes Franchini, Ana Carolina Migliorini Figueira, Celso Eduardo Benedetti, Paulo Sergio Lopes de Oliveira
Structural dynamics of SARS-CoV-2 nucleocapsid protein induced by RNA binding. PLoS computational biology 18 (5) (2022)
Beatriz C Moraes, Helder Veras Ribeiro-Filho, Allan P Roldão, Elaine F Toniolo, Gustavo P B Carretero, Germán Gustavo Sgro, Fernanda Aparecida Heleno Batista, Damian E Berardi, Victória Regina da Silva Oliveira, Rebeka Tomasin, Felipe Monteleone Vieceli, Dimitrius T Pramio, Alexandre B Cardoso, Ana Carolina Migliorini Figueira, Chuck Shaker Farah, Lakshmi A Devi, Camila Squarzoni Dale, Paulo Sergio Lopes de Oliveira, Deborah Schechtman
Structural analysis of TrkA mutations in patients with congenital insensitivity to pain reveals PLCγ as an analgesic drug target. Science signaling 15 (731) (2022)